Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics
Read More
Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program
Hemispherian raises seed funding for novel cancer therapeutics
World Leaders in Brain Cancer Join Hemispherian’s Clinical Advisory Board, Chaired by Dr. Roger Stupp
Hemispherian is delighted to announce its first granted patent
Hemispherian completes its seed financing and appoints Masha Strømme as Chair of the Board
Josipa Matic joins Hemispherian as Medicinal chemist. Welcome!
Hemispherian has been selected to pitch at DNB Healthcare Conference, Venture Session 2020
Hemispherian has been awarded NOK 14.6M from the Norwegian Research Council
Short introduction to Hemispherian
LSX Nordic Showcase
We are hiring! (CMC specialist)
Hemispherian wins grant from the European Commission
Inv€$tival Showcase Digital
LSX World Congress 2020
Swiss Nordic Bio 2020
Oslo Innovation Week 2019
Analyse Norge #7 / Dagens Næringsliv
DNB Nordic Healthcare Conference
